Please login to the form below

Not currently logged in


This page shows the latest Remdesivir news and features for those working in and with pharma, biotech and healthcare.

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

The NEJM authors maintained that there are still questions revolving around administering remdesivir as a treatment for COVID-19. ... Should remdesivir be reserved for the treatment of patients with selected risk factors?

Latest news

More from news
Approximately 11 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Working together against COVID-19 Working together against COVID-19

    Gilead shared some positive updates on social media about remdesivir but did not address all HCP concerns. ... Subsequently, Gilead dropped remdesivir’s orphan drug designation based on its potential as a coronavirus treatment.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A subsequent leak about the apparent failure of remdesivir in a Chinese trial then dampened expectations again. ... Yet, it is unlikely that any of the drugs will be a panacea, with Jefferies analysts saying remdesivir “might be modestly helpful”.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    An experimental antiviral: Gilead’s remdesivir. Gilead’s remdesivir, an experimental antiviral drug, is arguably the most-talked about potential treatment for COVID-19. ... Lane is currently overseeing ongoing studies at the US National Institutes of

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...